Overview
No overview information available.
Indication
对急性白血病、恶性淋巴瘤、胃癌、肺癌、乳腺癌和卵巢癌等有䓬越疗效，对多柔比星、柔红霉素耐药的病例亦有效，并且脱发、口腔炎等均较轻。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2023/04/07 | Not Applicable | Not yet recruiting | The First Affiliated Hospital of Soochow University | ||
2023/02/13 | Phase 3 | Recruiting | |||
2020/02/05 | Phase 2 | UNKNOWN | Sun Yat-sen University | ||
2017/06/09 | Phase 2 | UNKNOWN | Sun Yat-sen University | ||
2017/02/07 | Phase 2 | UNKNOWN | Shandong University | ||
2016/03/30 | Phase 1 | Completed | |||
2012/09/21 | Phase 1 | Completed | Chinese PLA General Hospital |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Aclarubicin Hydrochloride for Injection | 国药准字H10920075 | 化学药品 | 注射剂 | 8/10/2020 | |
| Aclarubicin Hydrochloride for Injection | 国药准字H10910092 | 化学药品 | 注射剂(冻干) | 9/17/2019 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.